Rosiglitazone Plaque Study

Clinical trial NCT00123227 · UNKNOWN

Trial details

NCT number: NCT00123227
Sponsor: Royal Brompton & Harefield NHS Foundation Trust
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2 Vascular Diseases Hypertension

Start date: 2002-10-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.